The IP marketers at the University of Massachusetts must be doing something right; the school’s licensing income climbed from $37 million in fiscal 2008 to $73 million during fiscal 2009 — during a very challenging period for TTOs. UMass officials say this will likely vault the university to a “Top 10″ ranking nationwide. Earnings from UMass IP also soared in Fiscal Year 2009, which ended on June 30, largely due to UMass Medical School receiving a $30 million upfront payment from Merck & Co. for rights to a human monoclonal antibody combination for the treatment of clostridium difficile infection.

In recent years, according to the AUTM annual survey, UMass has ranked among the Top 15 nationwide in IP income of reporting institutions. “Research and discovery are crucial to the Commonwealth’s innovation economy and will drive economic renewal and recovery in this state and across the nation,” says university President Jack Wilson.

Source: Innovation @ UMB

Posted November 3rd, 2009 under Intellectual Property Marketing

Write a comment